Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 1997Antimicrobial Agents and ChemotherapyOpen Access

A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate

View Full Paper
Ask AI
Bookmark
Share

Authors

DSD. SirotLaboratoire de Biotechnologie et Chimie MarinesCRC. ReculeCentre Hospitalier Universitaire de GrenobleECEl Bachir ChaibiCentre National de la Recherche Scientifique

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sirot et al. (1997) studied this question.

synapsesocial.com/papers/6a1af5aee916fa6dd3b92cfdhttps://doi.org/10.1128/aac.41.6.1322
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1beta-Lactamases in laboratory and clinical resistance1995 · 1,743 citations
  2. 2Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coli1995 · 112 citations
  3. 3Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 beta-lactamase genes1992 · 62 citations
  4. 4β‐lactamase TEM1 of <i>E. coli</i> Crystal structure determination at 2.5 Å resolution1992 · 73 citations
  5. 5Multiple substitutions at position 104 of <i>β</i>-lactamase TEM-1: assessing the role of this residue in substrate specificity1995 · 57 citations